In a Korea report initiated by Kim MJ et al. 15, the impact of polymorphisms in the AKT1 gene on OS and disease-free survival(DFS) in 310 patients with surgically resected NSCLC were evaluated, and indicated that OS and DFS were significantly higher for patients with the AA genotype of AKT1: rs3803300 than those with GA/GG genotype. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.